Cited by 348Health Systems, Economic Evaluations, Quality of LifeSimulation Techniques and ApplicationsStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3

Siebert, Uwe, Alagoz, Oguzhan, Bayoumi, Ahmed M., Jahn, Beate, Owens, Douglas K., Cohen, David J., Kuntz, Karen M.·2012·Medical Decision Making

DOI 10.1177/0272989x12455463

Open this paper in CoChat — free account

Abstract

State-transition modeling (STM) is an intuitive, flexible, and transparent approach of computer-based decision-analytic modeling, including both Markov model cohort simulation as well as individual-based (first-order Monte Carlo) microsimulation. Conceptualizing a decision problem in terms of a set of (health) states and transitions among these states, STM is one of the most widespread modeling techniques in clinical decision analysis, health technology assessment, and health-economic evaluation. STMs have been used in many different populations and diseases, and their applications range from personalized health care strategies to public health programs. Most frequently, state-transition models are used in the evaluation of risk factor interventions, screening, diagnostic procedures, treatment strategies, and disease management programs.

Integrity signals

Registry

Crossref · 10.1177/0272989x12455463

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Markov Decision Processes
Puterman, M. L. (1994) · Wiley series in probability and statistics · doi:10.1002/9780470316887 · Cited by 6,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957
Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12458348 · Cited by 887
Model Transparency and Validation
Eddy, D. M., Hollingworth, W., Jaime, J., Tsevat, J., McDonald, K. M., & Wong, J. B. (2012) · Medical Decision Making · doi:10.1177/0272989x12454579 · Cited by 803
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.014 · Cited by 711
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
Sanders, G. D., Bayoumi, A. M., H, V. S. M. P., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042657 · Cited by 603
Self-citation

Show all 59 references

Research works printed but not linked: 2

Robins JM, 2004, Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Vol. 1, 2191
Sonnenberg FA, 1994, Med Care, 32, JS52

Sorted by citations

Items 301–348 of 348

Using economic evaluation and preference elicitation methods to inform decisions about how best to reorganise services : a case study of the redesign of emergency medical services
Bhattarai, N. (2019)
Impact and cost-effectiveness of nonavalent human papillomavirus vaccination in Switzerland: insights from a dynamic transmission modelPreprint
Riesen, M., Bogaards, J. A., Low, N. N., & Althaus, C. L. (2019) · medRxiv · doi:10.1101/19012674
Conceptualizing IT Project Portfolio Management in Terms of Organisational State-Transition Approach
Sarbazhosseini, H. (2020) · Lecture notes in business information processing · doi:10.1007/978-3-030-44322-1_43
The Optimal Control of Child Delivery for Women with Hypertensive Disorders of Pregnancy
Demirtas, A. (2018)
Health economic modeling to optimize the HIV care continuum: methods and applications
Zang, X. (2020) · Summit (Simon Fraser University)
Overview of cost-effectiveness analysis and health state utilities in multiple myeloma and estimations of health state utilities from real-world macedonian data
Qerimi, V., Nestorovska, A. K., Sterjev, Z., Genadieva-Stavric, S., & Suturkova-Milosevic, L. (2016) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2016.62.02.003
HPV VACCINATION AS A TOOL TO REDUCE SOCIOECONOMIC DISPARITIES IN CANCER
Spencer, J. C. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/q1t4-sa96
Economics of HIV Vaccines and HIV Vaccine Research and Development
Chen, S. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Estimation of Hepatitis C Prognosis to Inform Treatment Prioritization Decisions
Erman, A. (2020) · TSpace (University of Toronto)
The Development of a Microsimulation Model to Evaluate the Cost-utility of Telemonitoring for Patients with Heart Failure in Ontario, Canada
Boodoo, C. (2020) · TSpace (University of Toronto)
How Many of Those Things Do We Really Need? Discrete Event Simulation
Day, T. E., Dong, Y., & Gopakumar, B. (2021) · Comprehensive healthcare simulation · doi:10.1007/978-3-030-72973-8_25
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomes
Ward, M. J., Douin, D. J., Gong, W., Ginde, A. A., Hough, C. L., Exline, M. C., Tenforde, M. W., Stubblefield, W. B., Steingrub, J. S., Prekker, M. E., et al. (2022) · Journal of Clinical and Translational Science · doi:10.1017/cts.2022.393
Chronic Disease Modeling
Habbema, J. D. F., Boer, R., & Barendregt, J. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00072-2
Worked Example in Cost-Utility Analysis
Espinoza‐Espinoza, G., & Zaror, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-96289-0_9
Transfer of literature data to virtual patient cases: Development and implementation of a method to generate categorical data using Bernoulli-distributed random valuesPreprint
Schmidt, C., Kesztyüs, D., Haag, M., Wilhelm, M. G., & Kesztyüs, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1960819/v1
Spezielle Ansätze der Ökonomik
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-22262-7.00057-0
Verknüpfung von randomisierten kontrollierten Studien und Real World Data
Friede, T., Röver, C., & Mathes, T. (2023) · Prävention und Gesundheitsförderung · doi:10.1007/s11553-023-01016-9
Medical decision analysis in practice: advanced methods
Sox, H. C., Higgins, M. C., Owens, D. K., & Sanders, G. D. (2024) · Medical Decision Making · doi:10.1002/9781119627876.ch14
Self-citation
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
Lindsay, D., Schofield, P. E., Roberts, M. J., Yaxley, J. W., Quinn, S. J., Richards, N., Frydenberg, M., Gardiner, R. A., Lawrentschuk, N., Juraskova, I., et al. (2024) · European Urology Oncology · doi:10.1016/j.euo.2024.08.005
Using Joint Longitudinal and Time-to-Event Models to Improve the Parameterization of Chronic Disease Microsimulation Models: an Application to Cardiovascular DiseasePreprint
Giardina, J., Haneuse, S., & Pandya, A. (2024) · medRxiv · doi:10.1101/2024.10.27.24316240
An Early-Stage Economic Evaluation of Superabsorbent Wound Dressings for the Management of Moderately to Highly Exuding Leg Ulcers in Slovakian Settings
Veličković, V. M., Serafin, A., Arlouskaya, Y., Milde, T.-C., & Halász, B. G. (2024) · Advances in Skin & Wound Care · doi:10.1097/asw.0000000000000232
Empirical calibration of a simulation model of opioid use disorder
Madushani, R. W. M. A., Wang, J., Weitz, M., Linas, B. P., White, L. F., & Chrysanthopoulou, S. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0310763
Modeling cost-effectiveness analysis of treatment sequencing
del Campo, C., Bai, J., & Keller, L. R. (2025) · Socio-Economic Planning Sciences · doi:10.1016/j.seps.2025.102210
Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity
Ekwueme, D. U., Reagan, K. A., Kao, S. Z., Dasari, S. R., Kenney, K. M., Wu, M., Thompson, T., & Miller, J. W. (2025) · Cancer Causes & Control · doi:10.1007/s10552-025-02006-2
Cost-Effectiveness and Budget Impact of Telehealth Psychological Services for Mental Health Disorders in Australia: A Retrospective Economic Evaluation (Preprint)
Olaleye, A. O., Kabir, E., & Khanam, R. (2025) · JMIR Mental Health · doi:10.2196/77652
The Uneven Path of Psychological Distress: How Socioeconomic Status Shapes Distress Transitions in Australian Adults
Husnain, M. I. U., Hajizadeh, M., Ahmad, H., & Khanam, R. (2025) · Value in Health · doi:10.1016/j.jval.2025.10.005
Exploring Markov modeling approaches for the health economic assessment of circulating tumor cells in the management of metastatic prostate cancer patients
Kenter, W. (2015) · doi:10.13140/rg.2.1.3698.6960
Additional file 1 of The IMPROVE trial: study protocol for a pragmatic cluster randomised controlled trial to assess the effectiveness of using lay health workers to improve uptake and completion of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Gilworth, G., Harris, K., Morgan, T., Ayis, S., Fox-Rushby, J. A., Godfrey, E., Hopkinson, N. S., Lewin, S. A., Lim, K. K., Spinou, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695110
Simulation of Human Behaviour in Adherence to Preventive Health Programmes - A Methodological Proposal and an Example of Its Application
Pereira, A. P., Laureano, R. M. D. S., & Neto, F. B. D. L. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-12882-9_9
Development of the health economic model for type 2 diabetes considering glycaemic variability
Gu, Z., Chen, L., Zhan, K., Xi, X., & Wang, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70451
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO Study
Kontiainen, J., Lehtomäki, K., Muhonen, T. T., Hahl, J., Toppila, I., Poussa, T. A., Österlund, E., Heervä, E., Stedt, H., Kallio, R., et al. (2026) · Acta Oncologica · doi:10.2340/1651-226x.2026.45005
Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data
Porta, C., Pradelli, L., Cirotto, G., Majorini, M. T., Garay, O. U., Calvaruso, V., Fasano, T., Napoli, L., Foschi, F. G., & Lampertico, P. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2627833
A Microsimulation Model to Assess the Cost-Effectiveness of Physical Activity Policies Among US Adults: The Physical Activity, Diabetes, and Cardiovascular Disease Model
Neuwahl, S. J., Hoerger, T. J., Allaire, B. T., Hilscher, R., Onufrak, S. J., Chen, Y., Whitfield, G. P., Wang, Y., & Zhang, P. (2026) · Journal of Physical Activity and Health · doi:10.1123/jpah.2025-0237
Enhanced patient outcomes and improved budget impact from increased PFO diagnostic testing in cryptogenic stroke workup: a US hospital perspective
Volpi, J. J., Tiozzo, G., Neervoort, J., Louwsma, T., Marti, A., Landaas, E. J., Nakum, M., & Imhoff, R. J. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2630603
Management of moderate-to-highly exuding leg ulcers with polyacrylate superabsorbent wound dressings versus foam dressings in spanish settings: an early-stage cost-effectiveness and budget-impact analysis
Veličković, V. M., Torra‐Bou, J. E., Lombardo, F. C., & Llatas, F. P. (2026) · Journal of Medical Economics · doi:10.1080/13696998.2026.2636435
Evaluation Médico-Economique de la toxine botulique dans la prise en charge des Douleurs pelviennes chroniques à partir de deux types d’analyses (étude en vie réelle et Modélisation) : application à la Dysménorrhée et comparaison des résultats
Kouame, K. J. M. (2023) · doi:10.70675/f5bcd7d0zb874z474fzab5dz1d19a5ad1faa
Impact of Smoothing and Modeling Approach on Quality-Adjusted Life Expectancy Estimates
Ameri, H., & Poder, T. G. (2026) · Value in Health · doi:10.1016/j.jval.2026.03.2241
Clinical Impact and Cost-effectiveness of Everolimus Combination Therapy in Liver Transplant Recipients: Focus on the Risk of Cancer, Infection, and Renal Function
Jang, S., Kim, G., Lim, Y., Kim, H., & Lee, E. (2026) · Transplantation · doi:10.1097/tp.0000000000005688
Cost-effectiveness of multiarterial versus single-arterial grafting in coronary artery bypass surgery
Odewade, N., Bikdash, R., Brooks, E. S., Otchere, P., Kubi, B., Sabatino, M. E., Hirji, S. A., Sundt, T. M., Osho, A. A., Sabe, A. A., et al. (2026) · JTCVS Open · doi:10.1016/j.xjon.2026.101834
How accurate should a precision medical test be to meet cost-effectiveness
Chen, E., Zeng, X., & Jin, H. (2026) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-026-00752-x
Economic Evaluation of Self-Administered Dual-Task Training Reducing Falls in Community-Dwelling Older Adults: Cost-Effectiveness Analysis of a Multicenter Randomized Control Trial
Khan, M. J., Fong, K. N. K., Wong, T. W. L., Tsang, W. W.-N., Chan, W. C., Chen, C., & Winser, S. J. (2026) · Journal of Physical Activity and Health · doi:10.1123/jpah.2025-0252
Markov modeling in R: Advanced method using a cost-effectiveness analysis
Kouame, K. J. M., Kouakou, C. R. C., Gnanou, S., Yacouba, B., & Siani, C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350698
Cost-effectiveness of short implants (6–8.5 mm) compared to regular length implants (> 10 mm) with bone regeneration in posterior atrophic mandible: a 8-year microsimulation model
Sáenz‐Ravello, G., Baeza, M., Fan, S., De-la-Rosa-Gay, C., Valmaseda‐Castellón, E., & Mattheos, N. (2026) · BMC Oral Health · doi:10.1186/s12903-026-09152-2
From mechanistic models to artificial intelligence: exploring the potential of digital twins in geriatric oncology
Karampelesis, P., Denazis, S., Koufopavlou, O., & Zacharaki, E. I. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1760912
Intrathecal pump refills at home or at the hospital: Protocol for a randomized controlled crossover trial—The IMPROVE study
Hoey, U. V., Winnepenninckx, B., Moens, M., Putman, K., & Goudman, L. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354092
Age Limits of Breast Cancer Screening with Mammography—A Decision-Analytic Benefit–Harm Evaluation to Inform Decision Making for the German Context
Sroczynski, G., Hallsson, L. R., Mühlberger, N., Kühne, F., Jahn, B., Henning, C., Kölsch, H., Sauerland, S., Angelescu, K., & Siebert, U. (2026) · Cancers · doi:10.3390/cancers18172750
Self-citation
Modeling Framework for Economic Evaluation of Disease-Modifying Therapies in Parkinson’s Disease: Evidence Review and Expert Opinion
Shah, A., Dodel, R. C., Kharawala, S., Klapper, K., May, M., Odin, P., Asis, A., Pagano, G., Kotzeva, A., & Carroll, C. (2026) · PharmacoEconomics · doi:10.1007/s40273-026-01669-2
Modeling Patient Care Pathways as Markov Chains
Siddiqui, N. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9705-4.ch005

Authors: Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M.
Affiliations: St. Michael's Hospital (CA)
UMIT–University for Health Sciences, Medical Informatics and Technology,Hall/Tyrol, Austria (US)
ORCID: Siebert, Uwe
Bayoumi, Ahmed M.
Jahn, Beate
Cohen, David J.
Kuntz, Karen M.
Venue: Medical Decision Making
Publisher: SAGE Publications
Published: 2012-09
Volume: 32
Issue: 5
Pages: 690-700
ISSN: 0272-989X (ISSN-L)
1552-681X
DOI: 10.1177/0272989x12455463
OpenAlex: W2132708603
Cited by: 348
References: 59
Citations by year: 2026: 23 · 2025: 23 · 2024: 19 · 2023: 18 · 2022: 28 · 2021: 23 · 2020: 29 · 2019: 25 · 2018: 24 · 2017: 29 · 2016: 25 · 2015: 32 · 2014: 21 · 2013: 19 · 2012: 8
FWCI: 61.24
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Medical Decision Making (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Decision Sciences › Management Science and Operations Research › Simulation Techniques and Applications
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: state transition modeling, Monte Carlo simulation, clinical decision analysis, health technology assessment, health economic evaluation, health states, risk factor intervention, screening, diagnostic procedures, treatment options, disease management programs
MeSH terms: Decision Making, Markov Chains, Models, Theoretical, Cohort Studies, Benchmarking

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks